Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Anti-Cancer Agents in Medicinal Chemistry|February 10, 2021
COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic MethodsFaroogh Marofi, Ramyar Azizi, Roza Motavalli, et al.
International Journal of Rheumatic Diseases|June 13, 2023
Immunogenicity of COVID-19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta-analysisMaysoon Al-Haideri, Talar Ahmad Merza Mohammad, Shahram Darvishzadehdeldari, et al.
Cancer Cell International|October 24, 2025
Long non-coding RNAs: key orchestrators of macrophage polarization in breast cancerFarid Ghorbaninezhad, Ahmad Ghorbani Vanan, Samaneh Rostami, et al.
Clinical and Experimental Medicine|July 8, 2025
Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progressionAlireza Azani, Malihe Sharafi, Reyhaneh Doachi, et al.
Heliyon|August 15, 2024
Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromesYasaman Goudarzi, Khaterehsadat Monirvaghefi, Salar Aghaei, et al.
Journal of Cellular Physiology|December 29, 2020
Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patientsSafa Tahmasebi, Mohamed A El-Esawi, Zaid Hameed Mahmoud, et al.
Stem Cell Reviews and Reports|December 27, 2025
Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian CancerAlireza Azani, Sahar Hasani, Malihe Sharafi, et al.
Journal of Cellular Physiology|September 14, 2020
Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controlsArmin Sadeghi, Safa Tahmasebi, Arshad Mahmood, et al.
Clinical and Experimental Medicine|May 31, 2026
Exosomal lncRNAs as molecular switches driving macrophage-tumor co-evolution in breast cancerMahsa Javadian, Tahereh Zeinali, Morteza Rajabi, et al.
Pageof 6